This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Luye Innomind Pharma Shijiazhuang Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jingwei Tian: Innovator in VMAT2 Inhibition
Introduction
Jingwei Tian is a prominent inventor based in Yantai, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit VMAT2. His work is crucial for advancing treatments for diseases associated with this target.
Latest Patents
Jingwei Tian holds a patent for a VMAT2 inhibitor and its preparation method. The patent describes a class of compounds that serve as VMAT2 inhibitors, specifically focusing on a compound represented by formula (I), or its stereoisomers or pharmaceutically acceptable salts. This invention is pivotal for the preparation of medicaments aimed at treating diseases related to VMAT2.
Career Highlights
Tian is associated with Luye Innomind Pharma Shijiazhuang Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in developing VMAT2 inhibitors showcases his commitment to improving healthcare solutions.
Collaborations
Jingwei Tian collaborates with notable colleagues, including Dawei Yu and Rui Zhang. Their combined efforts contribute to the advancement of research and development in their field.
Conclusion
Jingwei Tian's work in developing VMAT2 inhibitors represents a significant advancement in medical science. His contributions are essential for the future of treatments targeting VMAT2-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile